ARTICLE | Clinical News
Istradefylline: Phase III data
March 13, 2006 8:00 AM UTC
Data from a placebo-controlled, North American Phase III trial in 610 patients showed that istradefylline missed the primary endpoint. But the compound showed a significant improvement in motor functi...